VIVO Cannabis has signed a distribution agreement with Burleigh Heads Cannabis , one of Australia‘s leading medicinal cannabis distributors. According to the company, the agreement is expected to increase the ability of Australian patients to access VIVO’s high-quality medicinal cannabis flower, oil and other products via approved channels.
"The required regulatory import permits necessary to enable the first shipment of product under the agreement have been granted by the Australia Office of Drug Control, and we expect to import the first shipment of VIVO products in June, subject to receipt of a Canadian export permit," the team with the company explains.
Barry Fishman, CEO of VIVO, states, “We are very excited to announce the signing of this distribution agreement, which will give us increased exposure in the Australian market and enhance consumer awareness of our brand and products. Burleigh Heads is a strong advocate for improving patient access to safe cannabis medicines and, together with its affiliate, CDA Clinics Australia, is a leader in providing Australian patients with channels through which to acquire high-quality cannabis products.”
Guy Headley, Director of Operations of Burleigh Heads, commented, “We are impressed with VIVO’s commitment to product quality and patient access. We look forward to providing Australian patients and doctors with another quality medicinal cannabis treatment option. We also look forward to continuing this relationship with VIVO as their product portfolio expands.”
For more information: